Father Shares Hopeful Autism Treatment Progress
American businessman Matthew Belsky announced a noticeable improvement in his son’s condition, who is severely autistic, after receiving an experimental treatment called L1-79. The developments included increased eye contact, better interaction with his parents, the use of a letter board, and beginning to eat solid foods, all following special approval from the FDA. The company developing the drug aims to enhance communication and social skills. Results from the second phase of clinical trials over a 12-week period showed improvements in communication and speech skills without serious side effects; however, the findings are still under medical review and evaluation.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)